These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8562594)

  • 21. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ; García I; Pascual A
    Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photocleavage of DNA by the fluoroquinolone antibacterials.
    Martínez L; Chignell CF
    J Photochem Photobiol B; 1998 Aug; 45(1):51-9. PubMed ID: 9819899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Highperformance liquid chromatographic assay for lomefloxacin in plasma and its pharmacokinetics in healthy volunteers].
    Tan L; Xu DK; Diao Y; Yuan YS
    Yao Xue Xue Bao; 1993; 28(4):286-9. PubMed ID: 8213172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM; Lee GC; Ellis ME
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of lomefloxacin by terbium sensitized chemiluminescence method.
    Nie LH; Zhao HC; Wang X; Yi L; Lu Y; Jin LP; Ma HM
    Anal Bioanal Chem; 2002 Dec; 374(7-8):1187-90. PubMed ID: 12474083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lomefloxacin clinical pharmacokinetics.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereospecific high-performance liquid chromatographic assay of lomefloxacin in human plasma.
    Foster RT; Carr RA; Pasutto FM; Longstreth JA
    J Pharm Biomed Anal; 1995 Sep; 13(10):1243-8. PubMed ID: 8562596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of 19F NMR spectroscopy to a study of carbon monoxide binding to human hemoglobin modified at Cys-beta 93 with the S-trifluoroethyl residue.
    Knowles FC
    Arch Biochem Biophys; 1984 Apr; 230(1):327-34. PubMed ID: 6712242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of new quinolones in the blood of elderly patients.
    Morita M; Hasuda A; Nakagawa H; Abe Y; Suzuki K
    J Int Med Res; 1993; 21(6):334-41. PubMed ID: 8143888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial effects of lomefloxacin in vitro.
    Chambers ST; Peddie BA; Robson RA; Begg EJ; Boswell DR
    J Antimicrob Chemother; 1991 Apr; 27(4):481-9. PubMed ID: 1856127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T; Fujimura A; Shiga T; Sasaki M; Harada K; Tateishi T; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 31P-NMR measurements of ATP, ADP, 2,3-diphosphoglycerate and Mg2+ in human erythrocytes.
    Petersen A; Kristensen SR; Jacobsen JP; Hørder M
    Biochim Biophys Acta; 1990 Aug; 1035(2):169-74. PubMed ID: 2393665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ; Cornel JH; Martea M; Vree TB
    Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT; Nix DE
    Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lomefloxacin (NY-198 or SC 47111): in vitro evaluations of a new fluoroquinolone.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-105S. PubMed ID: 2791492
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of lomefloxacin in the treatment of chronic prostatitis.
    Scelzi S; Travaglini F; Nerozzi S; Dominici A; Ponchietti R; Novelli A; Rizzo M
    J Chemother; 2001 Feb; 13(1):82-7. PubMed ID: 11233805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies.
    Tewson TJ; Yang D; Wong G; Macy D; DeJesus OJ; Nickles RJ; Perlman SB; Taylor M; Frank P
    Nucl Med Biol; 1996 Aug; 23(6):767-72. PubMed ID: 8940719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
    Rizk E
    Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
    Leigh DA; Harris C; Tait S; Walsh B; Hancock P
    J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.